
Resignation of Chief Partnership Officer

Basel Medical Group Full-Year 2025 Earnings Report

Resignation of Chief Partnership Officer

Basel Medical Group Full-Year 2025 Earnings Report
Appointment of Chief Commercial Officer
Singapore – August 15, 2025 – Basel Medical Group Ltd
Basel Medical Group Appoints Darren Tan as Chief Commercial Officer
SINGAPORE – August 15, 2025 – Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that its Board of Directors has appointed Mr. Tan Boon Chye (Darren) as the Company’s Chief Commercial Officer, effective immediately.
In his new role as Chief Commercial Officer, Mr. Tan will be responsible for driving the Company's global commercial strategy, including market expansion and revenue growth across all business units.
A Strategic Leader with Proven Entrepreneurial Success
Mr. Tan brings nearly two decades of diverse experience in business consulting, corporate development, financing, and marketing to Basel Medical Group. Since beginning his entrepreneurial journey in 2007, he has co-founded multiple companies across diverse industries, demonstrating a strong track record of successful business growth and execution.
A graduate of the University of London (BSc Accounting & Finance), Mr. Tan’s leadership and business acumen have been widely recognized. He is a recipient of the 2010 Successful Entrepreneur Award (Platinum Category) and the 2011 SME1 Asia Emerging Award, and his work has been featured by prominent media outlets, including Channel News Asia, Global Business Magazine, and Phoenix Satellite TV.

